The impact of 2013 UK NICE guidelines on the management of varicose veins at the Heart of England NHS Foundation Trust,Birmingham,UK

Abstract

Objective

Although varicose veins are a common cause of morbidity, the UK National Health Service and private medical insurers have previously sought to ration their treatment in a non-evidence based manner in order to limit health-care expenditure and reimbursement. In July 2013, the UK National Institute for Health and Care Excellence published new national Clinical Guidelines (CG168) to promote evidence-based commissioning and management of varicose veins. The aim of this study was to evaluate the impact of CG168 on the referral and management of varicose veins at the Heart of England NHS Foundation Trust, Birmingham, UK.

Methods

Interrogation of a prospectively gathered database, provided by the Heart of England NHS Foundation Trust Performance Unit, of patients undergoing interventions for varicose veins since 1 January 2012. Patients treated before (group 1) and after (group 2) publication of CG168 were compared.

Results

There were 253 patients, 286 legs (48% male, mean (range) age 54 (20–91) years) treated in group 1, and 417 patients, 452 legs, (46% male, mean (range) age 54 (14–90) years) treated in group 2, an increase of 65%. CG168 was associated with a significant reduction in the use of surgery (131 patients (52%) group 1 vs. 127 patients (30%) group 2, p = 0.0003, χ²), no change in endothermal ablation (30 patients (12%) group 1 vs. 45 patients (11%) group 2), a significant increase in ultrasound-guided foam sclerotherapy (92 patients (36%) group 1 and 245 patients (59%) group 2, p = 0.0001, χ²) and an increase in treatment for C2/3 disease (53% group 1 and 65.2% group 2, p = 0.0022, χ²).

Conclusions

Publication of National Institute for Health and Care Excellence CG168 has been associated with a significant increase (65%) in the number of patients treated, referral at an earlier (CEAP C) stage and increased use of endovenous treatment. CG 168 has been highly effective in improving access to, and quality of care, for varicose veins at Heart of England NHS Foundation Trust.

Keywords

Varicose veins endovenous ablation foam sclerotherapy NICE guidelines

Get full access to this article

View all access options for this article.

References

Robertson

Evans

Lee

. Incidence and risk factors for venous reflux in the general population: Edinburgh Vein Study. Eur J Vasc Endovasc Surg 2014; 48: 208–214.

Kaplan

Criqui

Denenberg

. Quality of life in patients with chronic venous disease: San Diego population study. J Vasc Surg 2003; 37: 1047–1053.

Graham

Harrison

Shafey

. Knowledge and attitudes regarding care of leg ulcers. Survey of family physicians. Can Fam Physician 2003; 49: 896–902.

Persoon

Heinen

van der Vleuten

. Leg ulcers: a review of their impact on daily life. J Clin Nurs 2004; 13: 341–354.

Gloviczki

Comerota

Dalsing

. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53: 2s–48s.

Allaert

Cazaubon

Causse

. Venous disease and ergonomics of female employment. Int Angiol 2005; 24: 265–271.

NICE. Referral Advice: a guide to appropriate referral from general to specialist services, 2001.

NICE. Guidelines CG168, varicose veins in the legs: the diagnosis and management of varicose veins, 2013.

Eklof

Rutherford

Bergan

. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004; 40: 1248–1252.

10.

NICE. NICE support for commissioning for varicose veins in the legs, 2014.

11.

RCS Va. Commissioning Guide: Varicose Veins, 2013.

12.

Berridge

Bradbury

Davies

. Recommendations for the referral and treatment of patients with lower limb chronic venous insufficiency (including varicose veins). Phlebology 2011; 26: 91–93.

13.

Lurie

Kistner

. Trends in patient reported outcomes of conservative and surgical treatment of primary chronic venous disease contradict current practices. Ann Surg 2011; 254: 363–367.

14.

Michaels

Campbell

Brazier

. Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). Health Technol Assess 2006; 10: 1–196, iii-iv.

15.

Pannier

Rabe

. The relevance of the natural history of varicose veins and refunded care. Phlebology 2012; 27(Suppl 1): 23–26.

16.

Cesarone

Belcaro

Nicolaides

. ‘Real’ epidemiology of varicose veins and chronic venous diseases: the San Valentino Vascular Screening Project. Angiology 2002; 53: 119–130.

17.

O'Leary

Chester

Jones

. Management of varicose veins according to reason for presentation. Ann R Coll Surg Engl 1996; 78: 214–216.

18.

Rabe

Pannier

. Societal costs of chronic venous disease in CEAP C4, C5, C6 disease. Phlebology 2010; 25(Suppl 1): 64–67.

19.

Niedzwiecki

. Endovenous thermal ablation of the saphenous vein. Semin Intervent Radiol 2005; 22: 204–208.

20.

Lurie

Creton

Eklof

. Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study). J Vasc Surg 2003; 38: 207–214.

21.

Darvall

Bate

Adam

. Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic primary great saphenous varicose veins. Eur J Vasc Endovasc Surg 2010; 40: 534–539.

22.

Darvall

Bate

Adam

. Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins. Eur J Vasc Endovasc Surg 2011; 42: 107–114.

23.

Darvall

Bate

Bradbury

. Patient-reported outcomes 5–8 years after ultrasound-guided foam sclerotherapy for varicose veins. Br J Surg 2014; 101: 1098–1104.

24.

Darvall

Sam

Bate

. Changes in health-related quality of life after ultrasound-guided foam sclerotherapy for great and small saphenous varicose veins. J Vasc Surg 2010; 51: 913–920.

25.

Davies

Popplewell

Darvall

. A review of randomised controlled trials comparing ultrasound-guided foam sclerotherapy with endothermal ablation for the treatment of great saphenous varicose veins. Phlebology 2015; 31: 234–240.